These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24740430)

  • 21. Maxadilan interacts with receptors for pituitary adenylyl cyclase activating peptide in human SH-SY5Y and SK-N-MC neuroblastoma cells.
    Eggenberger M; Born W; Zimmermann U; Lerner EA; Fischer JA; Muff R
    Neuropeptides; 1999 Apr; 33(2):107-14. PubMed ID: 10657479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pituitary adenylate cyclase-activating polypeptide prevents C2-ceramide-induced apoptosis of cerebellar granule cells.
    Vaudry D; Falluel-Morel A; Basille M; Pamantung TF; Fontaine M; Fournier A; Vaudry H; Gonzalez BJ
    J Neurosci Res; 2003 May; 72(3):303-16. PubMed ID: 12692897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) against apoptosis.
    Seaborn T; Masmoudi-Kouli O; Fournier A; Vaudry H; Vaudry D
    Curr Pharm Des; 2011; 17(3):204-14. PubMed ID: 21348830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous activation of pituitary adenylate cyclase-activating polypeptide receptors elicits antipodal effects on cyclic AMP and inositol phospholipid signaling pathways in CATH.a cells: role of protein synthesis and protein kinases.
    Muller A; Lutz-Bucher B; Kienlen-Campard P; Koch B; Loeffler JP
    J Neurochem; 1998 Apr; 70(4):1431-40. PubMed ID: 9523559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pituitary adenylate cyclase-activating peptide (PACAP) induces differentiation in the neuronal F11 cell line through a PKA-dependent pathway.
    McIlvain HB; Baudy A; Sullivan K; Liu D; Pong K; Fennell M; Dunlop J
    Brain Res; 2006 Mar; 1077(1):16-23. PubMed ID: 16487495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trazodone treatment protects neuronal-like cells from inflammatory insult by inhibiting NF-κB, p38 and JNK.
    Daniele S; Da Pozzo E; Zappelli E; Martini C
    Cell Signal; 2015 Aug; 27(8):1609-29. PubMed ID: 25911310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pituitary adenylate cyclase-activating polypeptide (PACAP(1-38)) enhances N-methyl-D-aspartate receptor function and brain-derived neurotrophic factor expression via RACK1.
    Yaka R; He DY; Phamluong K; Ron D
    J Biol Chem; 2003 Mar; 278(11):9630-8. PubMed ID: 12524444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide.
    Somogyvári-Vigh A; Reglodi D
    Curr Pharm Des; 2004; 10(23):2861-89. PubMed ID: 15379674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurotrophic and neuroprotective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on mesencephalic dopaminergic neurons.
    Takei N; Skoglösa Y; Lindholm D
    J Neurosci Res; 1998 Dec; 54(5):698-706. PubMed ID: 9843161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of IFN-gamma-induced janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.
    Delgado M; Ganea D
    J Immunol; 2000 Sep; 165(6):3051-7. PubMed ID: 10975815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotective potential of three neuropeptides PACAP, VIP and PHI.
    Dejda A; Sokołowska P; Nowak JZ
    Pharmacol Rep; 2005; 57(3):307-20. PubMed ID: 15985713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pituitary adenylate cyclase activating polypeptide protects cardiomyocytes against oxidative stress-induced apoptosis.
    Gasz B; Rácz B; Roth E; Borsiczky B; Ferencz A; Tamás A; Cserepes B; Lubics A; Gallyas F; Tóth G; Lengvári I; Reglodi D
    Peptides; 2006 Jan; 27(1):87-94. PubMed ID: 16095757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease.
    Reglodi D; Lubics A; Tamás A; Szalontay L; Lengvári I
    Behav Brain Res; 2004 May; 151(1-2):303-12. PubMed ID: 15084446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) induce phosphorylation of the transcription factor CREB in subpopulations of rat pinealocytes: immunocytochemical and immunochemical evidence.
    Schomerus C; Maronde E; Laedtke E; Korf HW
    Cell Tissue Res; 1996 Dec; 286(3):305-13. PubMed ID: 8929333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PACAP Attenuates Optic Nerve Crush-Induced Retinal Ganglion Cell Apoptosis Via Activation of the CREB-Bcl-2 Pathway.
    Ye D; Shi Y; Xu Y; Huang J
    J Mol Neurosci; 2019 Jul; 68(3):475-484. PubMed ID: 30993644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of endogenous antioxidant systems in the protective activity of pituitary adenylate cyclase-activating polypeptide against hydrogen peroxide-induced oxidative damages in cultured rat astrocytes.
    Douiri S; Bahdoudi S; Hamdi Y; Cubì R; Basille M; Fournier A; Vaudry H; Tonon MC; Amri M; Vaudry D; Masmoudi-Kouki O
    J Neurochem; 2016 Jun; 137(6):913-30. PubMed ID: 26991551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pituitary adenylate cyclase-activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death.
    Vaudry D; Rousselle C; Basille M; Falluel-Morel A; Pamantung TF; Fontaine M; Fournier A; Vaudry H; Gonzalez BJ
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6398-403. PubMed ID: 11972030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Convergent phosphomodulation of the major neuronal dendritic potassium channel Kv4.2 by pituitary adenylate cyclase-activating polypeptide.
    Gupte RP; Kadunganattil S; Shepherd AJ; Merrill R; Planer W; Bruchas MR; Strack S; Mohapatra DP
    Neuropharmacology; 2016 Feb; 101():291-308. PubMed ID: 26456351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PACAP deficiency sensitizes nigrostriatal dopaminergic neurons to paraquat-induced damage and modulates central and peripheral inflammatory activation in mice.
    Watson MB; Nobuta H; Abad C; Lee SK; Bala N; Zhu C; Richter F; Chesselet MF; Waschek JA
    Neuroscience; 2013 Jun; 240():277-86. PubMed ID: 23500093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuromodulatory effect of 4-(methylthio)butyl isothiocyanate against 3-nitropropionic acid induced oxidative impairments in human dopaminergic SH-SY5Y cells via BDNF/CREB/TrkB pathway.
    Kaur P; Attri S; Singh D; Rashid F; Singh S; Kumar A; Kaur H; Bedi N; Arora S
    Sci Rep; 2023 Mar; 13(1):4461. PubMed ID: 36932199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.